A Study to compare the additive advantage of Platelet rich Plasma in Erectile Dysfucntion.

A Prospective Comparative Analysis to Evaluate the Efficacy of Addition of Autologous Platelet rich Plasma Along with Standard Treatment Vs Standard Treatment Alone in Patients with Erectile Dysfunction - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109625

Enrollment

Registered

2026-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N529- Male erectile dysfunction, unspecified

Interventions

Intervention1: Platelet rich Plasma to be given intracavernosally in penis.: 30 ml venous blood drawn into TSC vacutainer using an 18-gauge hypodermic needle. Double-spin centrifugation method to

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria Adult men aged more than 18 years diagnosed with mild ED IIEF 5 score 17 to 21 and mild to moderate ED IIEF 5 score 12 to 16 Exclusion Criteria Adult men with IIEF 5 score less than 11 severe ED. Patient with history of Penile surgery or significant trauma. Patients with significant Psychological disorders

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
To study the mean change in IIEF-5 score after PRP injection at 1month after final treatment. To study the Proportion of patient attaining MCID in the IIEF-5 score at 1 month after final treatment. To study the Improvement in EHS score at 1 month after final treatment.Timepoint: Baseline before treatment and 1 month after completion of final treatment.	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactGajendra Pratap Singh

ATAL BIHARI VAJPAYEE INSTITUTE OF MEDICAL SCIENCES & DR RAM MANOHAR LOHIA HOSPITAL, NEW DELHI-110001

gajendra.julie@gmail.com7798652565

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026